10-Q: Lifeway Foods Reports Lower Profit Amidst Rising Costs

Lifeway Foods, Inc. announced a substantial decrease in net income and gross profit margins for the nine months ended September 30, 2026, despite a significant increase in net sales, primarily due to escalating input costs.

Summary

• Lifeway Foods, Inc. reported net sales of $67.8 million for Q3 2026, an 18.6% increase year-over-year, and $197.7 million for the first nine months of 2026, a 25.8% increase.
• However, gross profit decreased to 18.0% in Q3 2026 from 28.7% in Q3 2025, and to 21.5% for the nine months ended September 30, 2026, from 27.3% in the prior year.
• Net income for Q3 2026 was $0.26 million, a sharp decline from $3.53 million in Q3 2025. For the nine months ended September 30, 2026, net income was $5.06 million, down from $11.32 million in the same period of 2025.
• The company is experiencing significant increases in raw material input costs, particularly for Class II conventional milk, packaging, ingredients, and transportation.
• Lifeway is implementing price increases with customers to offset these rising costs, expected to take effect in Q4 2026 and Q1 2027.
• Significant capital expenditures are underway for the expansion and modernization of the Waukesha, Wisconsin facility, with an estimated total investment of $50.5 million.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significantly decreased net income and gross profit margins, despite increased net sales, driven by rising input costs.

Positives

• Net sales increased by 18.6% to $67.8 million in Q3 2026 and by 25.8% to $197.7 million for the first nine months of 2026, driven by higher volumes of branded drinkable kefir.
• The company has secured financing for its facility expansion and modernization project through its revolving credit facility and interim funding agreement.
• Lifeway Foods maintains compliance with its loan agreements and expects sufficient liquidity for its operations and growth initiatives.
• Investments in marketing activities are continuing to drive brand awareness and sales volume growth.

Negatives

• Gross profit margin significantly declined to 18.0% in Q3 2026 from 28.7% in Q3 2025, and to 21.5% for the nine months ended September 30, 2026, from 27.3% in the prior year.
• Net income for Q3 2026 was $0.26 million, a substantial decrease from $3.53 million in Q3 2025.
• Net income for the nine months ended September 30, 2026, was $5.06 million, a significant drop from $11.32 million in the same period of 2025.
• Rising input costs, including milk, packaging, ingredients, and transportation, are negatively impacting profitability.
• Selling expenses as a percentage of net sales increased to 9.5% in Q3 2026 and 10.2% for the nine months ended September 30, 2026, due to marketing investments.

Risks

• Continued elevated costs for milk, resin-based packaging, ingredients, and transportation are expected to persist in Q4 2026.
• The timing of customer price increases may not fully offset the impact of rising input costs.
• Evolving global trade policies could contribute to increased supply chain complexity and commodity cost volatility.
• Adverse economic conditions in the United States could impact consumer spending.
• Disruptions to the supply chain, manufacturing, or distribution capabilities due to various factors including labor shortages, natural disasters, or geopolitical tensions.

Future Outlook

The company anticipates that average prices per pound for conventional milk will be higher in Q4 2026 compared to Q3 2026. Elevated costs for packaging, ingredients, and transportation are also expected to continue. Price increases have been negotiated with customers, with implementation beginning in Q4 2026 and extending into Q1 2027. The expansion of the Waukesha facility is expected to increase manufacturing and packaging scale beginning in Q1 2027, with project completion anticipated in Q2 2027.

Management Comments

• The company believes that its cash flow from operations, revolving credit facility, interim funding agreement, and cash and cash equivalents will continue to provide sufficient liquidity for its working capital needs, capital resource requirements, and growth initiatives and to ensure the continuation of the Company as a going concern.
• We are in compliance with the terms of the Credit Agreement and expect to meet foreseeable financial requirements.
• The success of our business and financing strategies will continue to provide us with the financial flexibility to take advantage of various opportunities as they arise.
• If a serious economic or credit market crisis ensues, it could have a negative effect on our liquidity, results of operations and financial condition.

Industry Context

StockSavvy.ai notes that Lifeway Foods is experiencing industry-wide pressures related to rising commodity and packaging costs, which are impacting margins across the food and beverage sector. The company's strategy to pass these costs onto consumers through price increases is a common response, though the timing and customer acceptance of these increases are critical.

Comparison to Industry Standards

• Competitors in the cultured dairy and probiotic beverage market, such as Chobani and Danone (with its Activia brand), also face similar challenges with input cost inflation.
• The gross profit margin decline for Lifeway (to 18.0% in Q3 2026) is significantly lower than industry leaders in the broader dairy sector, where margins can often be higher, though this depends heavily on product mix and scale.
• The company's investment in expanding manufacturing capacity at its Waukesha facility aligns with industry trends of optimizing production for efficiency and meeting growing demand for health-focused products.

Legal Proceedings

• Lifeway is involved in various legal proceedings, claims, disputes, regulatory matters, audits, and proceedings arising in the ordinary course of business, including commercial disputes, product liabilities, intellectual property matters, and employment-related matters.
• Currently, no accruals for outstanding legal matters are material individually or in the aggregate, and management believes the ultimate resolution will not have a material adverse effect on the business, financial condition, results of operations, or cash flows.

Stakeholder Impact

• Shareholders may be impacted by the significant decrease in net income and profitability, potentially affecting stock valuation and dividends.
• Customers will experience price increases for conventional kefir products starting in Q4 2026.
• Employees may be affected by the company's investments in facility expansion and potential operational efficiencies gained.
• Suppliers of raw materials and packaging may see continued demand, but also face potential price negotiations from Lifeway.

Next Steps

• Implement price increases across the conventional kefir product portfolio with customers, beginning in Q4 2026.
• Continue monitoring macroeconomic conditions and global trade developments.
• Complete the expansion and modernization of the Waukesha, Wisconsin facility, with increased manufacturing and packaging scale expected in Q1 2027 and project completion in Q2 2027.
• Manage cash flow from operations, revolving credit facility, and interim funding agreement to fund working capital, capital requirements, and growth initiatives.

Key Dates

Recommendation

While net sales show strong growth, the significant decline in profitability due to rising input costs and the resulting margin compression warrants caution. The company's ability to successfully implement price increases and manage costs will be crucial. The ongoing facility expansion is a positive long-term investment, but near-term financial performance is concerning. Therefore, a 'hold' recommendation is appropriate pending clearer signs of margin recovery.

Keywords

kefir, cultured dairy, drinkable yogurt, cheese, probiotic, food manufacturing, input costs, supply chain